Aridis Pharmaceuticals ARDS

$ 0.31 17.91%

Quarterly report 2023-Q3
added 11-06-2023

Aridis Pharmaceuticals Financial Statements 2011-2024 | ARDS

Annual Financial Statements Aridis Pharmaceuticals

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	4.13 M	22.2 M	17.4 M	60 M	28.8 M	-	-	-	-	-	-	-
Shares	18.8 M	12.3 M	2.48 M	8.46 M	3.15 M	-	-	-	-	-	-	-
Historical Prices	0.22	1.81	7.02	6.91	8.36	-	-	-	-	-	-	-
Net Income	-30.4 M	-42.2 M	-22.3 K	-29.7 M	-22.1 M	-24.7 M	-8.42 M	-	-	-	-	-
Revenue	3.09 M	1.54 M	1 K	1.02 M	2.76 M	860 K	2.27 M	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	1 K	-	-	860 K	342 K	-	-	-	-	-
Operating Income	-30 M	-42.7 M	-22.4 M	-29.1 M	-24.1 M	-19.7 M	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-29.5 M	-42.3 M	-22.1 K	-28.7 M	-23.8 M	-19.7 M	-7.86 M	-	-	-	-	-
Operating Expenses	-	-	23.4 K	30.1 M	26.9 M	20.6 M	8.23 M	-	-	-	-	-
General and Administrative Expenses	7.16 M	7.31 M	6.44 M	6.03 M	3.87 M	3.16 M	1.96 M	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Aridis Pharmaceuticals

	2023-Q3	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	37.4 M	27 M	17.7 M	17.7 M	17.7 M	17.7 M	12.5 M	11.2 M	10.2 M	10.1 M	8.92 M	8.92 M	8.92 M	8.92 M	8.69 M	8.11 M	8.11 M	8.1 M	4.02 M	166 K	166 K	166 K	166 K	166 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-83 K	-	-8.24 M	-7.98 M	-7.77 M	-	-21 M	-5.49 M	-6.89 M	-	-5.79 M	-4.22 M	-6.5 M	-	-7.59 M	-8.38 M	-8.06 M	-	-7.91 M	-1.42 M	-7.33 M	-	-5.42 M	-6.08 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	417 K	-	399 K	292 K	1.19 M	-	515 K	33 K	-	-	1 M	1 M	-9 K	-	1.02 M	1.02 M	1.02 M	-	1.02 M	22 K	322 K	-	22 K	22 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-869 K	-	-7.41 M	-7.74 M	-7.42 M	-	-21 M	-6.23 M	-6.9 M	-	-5.79 M	-4.23 M	-6.56 M	-	-7.4 M	-8.27 M	-7.74 M	-	-6.62 M	-4.55 M	-7.37 M	-	-5.49 M	-3.98 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-811 K	-	-7.29 M	-7.48 M	-7.29 M	-	-20.7 M	-6.05 M	-6.81 M	-	-5.54 M	-4.06 M	-6.47 M	-	-7.14 M	-8.1 M	-7.65 M	-	-6.42 M	-4.43 M	-7.32 M	-	-5.46 M	-3.97 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	1.29 M	-	7.81 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	1.11 M	-	1.69 M	1.68 M	2.16 M	-	1.7 M	1.69 M	1.94 M	-	1.63 M	1.58 M	1.64 M	-	1.38 M	1.61 M	1.64 M	-	735 K	687 K	1.07 M	-	649 K	829 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency